Literature DB >> 15197738

Characterization of V642I-AbetaPP-induced cytotoxicity in primary neurons.

Takako Niikura1, Marina Yamada, Tomohiro Chiba, Sadakazu Aiso, Masaaki Matsuoka, Ikuo Nishimoto.   

Abstract

Amyloid precursor protein (AbetaPP), a precursor of amyloid beta (Abeta) peptide, is one of the molecules involved in the pathogenesis of Alzheimer's disease (AD). Specific mutations in AbetaPP have been found in patients inheriting familial AD (FAD). These mutant AbetaPP proteins cause cell death in neuronal cell lines in vitro, but the molecular mechanism of cytotoxicity has not yet been clarified completely. We analyzed the cytotoxic mechanisms of the London-type AbetaPP mutant, V642I-AbetaPP, in primary cortical neurons utilizing an adenovirus-mediated gene transfer system. Expression of V642I-AbetaPP protein induced degeneration of the primary neurons. This cytotoxicity was blocked by pertussis toxin, a specific inhibitor for heterotrimeric G proteins, Go/i, and was suppressed by an inhibitor of caspase-3/7 and an antioxidant, glutathione ethyl ester. A specific inhibitor for NADPH oxidase, apocynin, but not a xanthine oxidase inhibitor or a nitric oxide inhibitor, blocked V642I-AbetaPP-induced cytotoxicity. Among mitogen-activated protein kinase (MAPK) family proteins, c-Jun N-terminal kinase (JNK) and p38MAPK, but not extracellular regulated kinase (ERK), were involved in this cytotoxic pathway. The V642I-AbetaPP-induced cytotoxicity was not suppressed by two secretase inhibitors, suggesting that Abeta does not play a major role in this cytotoxicity. Two neuroprotective factors, insulin-like growth factor I (IGF-I) and Humanin, protected these primary neurons from V642I-AbetaPP-induced cytotoxicity. Furthermore, interleukin-6 and -11 also attenuated this cytotoxicity. This study demonstrated that the signaling pathway activated by mutated AbetaPP in the primary neurons is the same as that by the other artificial insults such as antibody binding to AbetaPP and the artificial dimerization of cytoplasmic domain of AbetaPP. The potential of neurotrophic factors and cytokines in AD therapy is also indicated. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15197738     DOI: 10.1002/jnr.20139

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  18 in total

1.  NOX activity in brain aging: exacerbation by high fat diet.

Authors:  Annadora J Bruce-Keller; Christy L White; Sunita Gupta; Alecia G Knight; Paul J Pistell; Donald K Ingram; Christopher D Morrison; Jeffrey N Keller
Journal:  Free Radic Biol Med       Date:  2010-03-25       Impact factor: 7.376

Review 2.  Role of APP Interactions with Heterotrimeric G Proteins: Physiological Functions and Pathological Consequences.

Authors:  Philip F Copenhaver; Donat Kögel
Journal:  Front Mol Neurosci       Date:  2017-01-31       Impact factor: 5.639

3.  Cognitive impairment in humanized APP×PS1 mice is linked to Aβ(1-42) and NOX activation.

Authors:  Annadora J Bruce-Keller; Sunita Gupta; Alecia G Knight; Tina L Beckett; Jessica M McMullen; Paulina R Davis; M Paul Murphy; Linda J Van Eldik; Daret St Clair; Jeffrey N Keller
Journal:  Neurobiol Dis       Date:  2011-07-28       Impact factor: 5.996

Review 4.  Humanin: after the discovery.

Authors:  Takako Niikura; Tomohiro Chiba; Sadakazu Aiso; Masaaki Matsuoka; Ikuo Nishimoto
Journal:  Mol Neurobiol       Date:  2004-12       Impact factor: 5.590

Review 5.  Humanin and the receptors for humanin.

Authors:  Masaaki Matsuoka; Yuichi Hashimoto
Journal:  Mol Neurobiol       Date:  2009-12-09       Impact factor: 5.590

6.  Structure analysis of activity-dependent neurotrophic factor 9 by circular dichroism and sedimentation equilibrium.

Authors:  Tsutomu Arakawa; Takako Niikura; Hirohisa Tajima; Fumio Arisaka; Yoshiko Kita
Journal:  J Mol Neurosci       Date:  2007-05-31       Impact factor: 3.444

Review 7.  Amyloid β precursor protein as a molecular target for amyloid β--induced neuronal degeneration in Alzheimer's disease.

Authors:  Elena Anahi Bignante; Florencia Heredia; Gerardo Morfini; Alfredo Lorenzo
Journal:  Neurobiol Aging       Date:  2013-05-25       Impact factor: 4.673

Review 8.  Protective effects of Humanin and calmodulin-like skin protein in Alzheimer's disease and broad range of abnormalities.

Authors:  Masaaki Matsuoka
Journal:  Mol Neurobiol       Date:  2014-06-27       Impact factor: 5.590

9.  Humanin inhibits neuronal cell death by interacting with a cytokine receptor complex or complexes involving CNTF receptor alpha/WSX-1/gp130.

Authors:  Yuichi Hashimoto; Megumi Kurita; Sadakazu Aiso; Ikuo Nishimoto; Masaaki Matsuoka
Journal:  Mol Biol Cell       Date:  2009-04-22       Impact factor: 4.138

10.  NOX activity is increased in mild cognitive impairment.

Authors:  Annadora J Bruce-Keller; Sunita Gupta; Taryn E Parrino; Alecia G Knight; Philip J Ebenezer; Adam M Weidner; Harry LeVine; Jeffrey N Keller; William R Markesbery
Journal:  Antioxid Redox Signal       Date:  2010-06-15       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.